Generation of strong ultralow-phase-noise microwave fields with tunable ellipticity for ultracold polar molecules
Review of Scientific Instruments · 01.04.2026 · 97 (4)
DOI: 10.1063/5.0314943 ↗Kurz gefasst
Fachartikel in der Zeitschrift Review of Scientific Instruments, online erschienen am 24.04.2026. Verfasst von Shrestha Biswas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Max-Planck-Institut für Quantenoptik, 85748 Garching, Germany. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Max Planck Society, European Union, Deutsche Forschungsgemeinschaft, Munich Center for Quantum Science and Technology.
Abstract (Originalsprache)
Microwave (MW) fields with strong field strength, ultralow phase-noise, and tunable polarization are crucial for stabilizing and manipulating ultracold polar molecules, which have emerged as a promising platform for quantum science. In this article, we present the design, characterization, and performance of a robust MW setup tailored for precise control of molecular states. This setup achieves a high electric field intensity of 6.9 kV/m in the near-field from a dual-feed waveguide antenna, enabling a Rabi frequency as high as 71 MHz for the rotational transition of sodium–potassium molecules. In addition, the low noise signal source and controlled electronics provide ultralow phase-noise and dynamically tunable polarization. Narrowband filters within the MW circuitry further reduce phase noise by more than 20 dB at 20 MHz offset frequency, ensuring prolonged one-body molecular lifetimes up to 10 s. We also show practical methods to measure the MW field strength and polarization using a simple homemade dipole probe and to characterize phase-noise down to −170 dBc/Hz using a commercial spectrum analyzer and a notch filter. Those capabilities allowed us to evaporatively cool our molecular sample to deep quantum degeneracy. Furthermore, the polarization tunability enabled the observation of field-linked resonances and facilitated the creation of field-linked tetramers. These techniques advance the study of ultracold polar molecules and broaden the potential applications of MW tools in other platforms of quantum science.
Autor:innen und Institutionen
- Max-Planck-Institut für Quantenoptik, 85748 Garching, Germany.
- Munich Center for Quantum Science and Technology, 80799 München, Germany.
- Technische Universität München, 80333 München, Germany.
- Vienna Center for Quantum Science and Technology, Atominstitut, TU Wien, 1020 Vienna, Austria.
- Fakultät für Physik, Ludwig-Maximilians-Universität, 80799 München, Germany.
ORCID-Profile: Shrestha Biswas, Sebastian Eppelt, Christian Buchberger, Xing-Yan Chen, Andreas Schindewolf, Michael Hani, Erwin Biebl, Immanuel Bloch, Xin-Yu Luo
Förderung
- Max Planck Society, European Union
- Deutsche Forschungsgemeinschaft
- Munich Center for Quantum Science and Technology
- Max Planck Harvard Research Center for Quantum Optics
Zitieren
APA
Biswas, S., Eppelt, S., Buchberger, C., Chen, X. Y., Schindewolf, A., Hani, M., Biebl, E., Bloch, I., & Luo, X. Y. (2026). Generation of strong ultralow-phase-noise microwave fields with tunable ellipticity for ultracold polar molecules. Review of Scientific Instruments, 97(4). https://doi.org/10.1063/5.0314943
Vancouver
Biswas S, Eppelt S, Buchberger C, Chen XY, Schindewolf A, Hani M, et al. Generation of strong ultralow-phase-noise microwave fields with tunable ellipticity for ultracold polar molecules. Review of Scientific Instruments. 2026;97(4). doi:10.1063/5.0314943
BibTeX
@article{Biswas2026,
author = {Biswas, Shrestha and Eppelt, Sebastian and Buchberger, Christian and Chen, Xing-Yan and Schindewolf, Andreas and Hani, Michael and Biebl, Erwin and Bloch, Immanuel and Luo, Xin-Yu},
title = {Generation of strong ultralow-phase-noise microwave fields with tunable ellipticity for ultracold polar molecules},
journal = {Review of Scientific Instruments},
year = {2026},
volume = {97},
number = {4},
doi = {10.1063/5.0314943}
}
EUVIMED